How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?

Fernández, Lucía

How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment? [electronic resource] - Transfusion 06 2018 - 1340-1347 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1537-2995

10.1111/trf.14573 doi


Blood Donors
Cell Culture Techniques--methods
Humans
Immunotherapy, Adoptive--methods
Interleukin-15--pharmacology
K562 Cells
Killer Cells, Natural--cytology
Lymphocyte Count
Methods
Neoplasms--therapy
T-Lymphocytes--cytology